Get the Stockscreener App
0.3927
6.52%
-0.0274
Curanex Pharmaceuticals Inc stock is traded at $0.3927, with a volume of 503.91K.
It is down -6.52% in the last 24 hours and up +46.53% over the past month.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
See More
Previous Close:
$0.4201
Open:
$0.411
24h Volume:
503.91K
Relative Volume:
0.13
Market Cap:
$11.13M
Revenue:
-
Net Income/Loss:
$-1.29M
P/E Ratio:
-8.5742
EPS:
-0.0458
Net Cash Flow:
$-9.72M
1W Performance:
-14.61%
1M Performance:
+46.53%
6M Performance:
-94.57%
1Y Performance:
+0.00%
1-Day Range:
$0.38
$0.4278
1-Week Range:
$0.38
$0.535
52-Week Range:
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Name
Curanex Pharmaceuticals Inc
Sector
Industry
Phone
718-673-6078
Address
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.3927 | 11.91M | 0 | -1.29M | -9.72M | -0.0458 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curanex Pharmaceuticals Inc Stock (CURX) Latest News
Curanex Forms World Class Scientific Advisory Board - The Manila Times
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
CURX Should I Buy - Intellectia AI
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Curanex Pharmaceuticals IncCommon Stock (Nasdaq:CURX) Stock Quote - The Chronicle-Journal
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
New plant-based ulcerative colitis drug targets FDA IND filing in 2026 - Stock Titan
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours - Sahm
Curanex Provides Operational Update on Key Regulatory Milestones - Bitget
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Announces CFO Transition - TradingView — Track All Markets
Curanex Pharmaceuticals Inc Announces Executive Changes - marketscreener.com
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to S&P TMI Index - MarketScreener
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Weekly Research Analysts’ Ratings Updates for Curanex Pharmaceuticals (CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) is looking forward to a strong quarter - setenews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Get insights into the top gainers and losers of Wednesday's pre-market session. - Chartmill
Curanex Pharmaceuticals Inc Stock (CURX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):